Eicher Motors Reports Q4 Net Profit of 1520 Crore Announces 3400 Crore Investment Plan Rupee Opens Weaker by 7 Paise at 9575 Against US Dollar Tracking Global Headwinds Warren Buffetts Timeless Investing Wisdom 3 Simple Rules for LongTerm Success Oil Prices Decline Amid Rising Hopes for USIran Nuclear Agreement Venture Global VG Highlighted as Potential Multibagger Stock for 2026 Sun Pharma Reports 26 Rise in Q4 Net Profit Driven by Strong Sales and Strategic Investments SNDL Q1 2026 Earnings NarrowerThanExpected Loss Amid Cost Discipline AES Q1 2026 Earnings EPS Surges 80 Above Estimates Stock Flat First Citizens BancShares Q1 2026 Earnings Earnings Surpass Estimates by Over 10 EverQuote Q1 2026 Earnings EPS Surpasses Expectations by 1402 Stock Declines Amid Unclear Revenue Outlook Identiv Inc INVE Q1 2026 Earnings EPS Falls Short of Estimates as Company Navigates Transition CREX Q1 2026 Earnings EPS Falls Sharply Below Estimates Despite Positive Stock Reaction Penske Automotive Group PAG Edges Higher as Key Support Holds Firm Aurinia Pharmaceuticals AUPH Retreats Testing Key Support After EarningsDriven Volatility Inhibrx Biosciences INBX Surges Over 5 Key Levels and What Lies Ahead Presidio Property Trust Series A SQFTW Gains Over 10 as Penny Stock Holds at 002 Whitehawk Therapeutics WHWK Edges Lower as Stock Hovers Near Key Support SK Hynix Achieves Record Profit in Fourth Quarter Fueled by AIDriven Chip Demand Canopy Growth CGC Q1 2026 Earnings Deep Loss Widens as Cannabis Operator Faces Margin Pressures Callaway Golf CALY Tests Support After Modest Decline Alight Inc Q1 2026 Earnings EPS Surprise Beats Estimates Stock Edges Higher Landstar System Inc LSTR Q1 2026 Earnings Modest EPS Beat Amidst Revenue Uncertainty AMAL Q1 2026 Earnings EPS Misses Estimates by 174 as Stock Declines KYMR Q1 2026 Earnings PreRevenue Biotech Beats EPS Estimates Stock Edges Lower CAMT Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises Northfield Bancorp Inc NFBK Q1 2026 Earnings EPS Beat Sends Shares Slightly Lower Amid Cautious Outlook Marker Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline